The correlation between SLC1A5 and GLUD1, which is involved in the conversion of Gln to alpha-ketoglutarate for the TCA cycle and subsequent gluconeogenesis, in luminal A tumours suggests that Gln is utilised for this process. Here, SLC1A5 is linked to neoplasm.